<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="BiolFront Cell Dev BiolFront. Cell Dev. Biol.Frontiers in Cell and" exact="Developmental" post="Biology2296-634XFrontiers Media S.A. doi: 10.3389/fcell.2020.00064 : Cell and Developmental"/>
 <result pre="and Developmental Biology2296-634XFrontiers Media S.A. doi: 10.3389/fcell.2020.00064 : Cell and" exact="Developmental" post="Biology: Review CD151 in Respiratory Diseases WongAmanda H.TranThai*[], Department"/>
 <result pre="doi: 10.3389/fcell.2020.00064 : Cell and Developmental Biology: Review CD151 in" exact="Respiratory" post="Diseases WongAmanda H.TranThai*[], Department of Physiology, Yong Loo Lin"/>
 <result pre="10.3389/fcell.2020.00064 : Cell and Developmental Biology: Review CD151 in Respiratory" exact="Diseases" post="WongAmanda H.TranThai*[], Department of Physiology, Yong Loo Lin School"/>
 <result pre="Medicine, a section of the journal Frontiers in Cell and" exact="Developmental" post="Biology epub: 2020-2-2collection: 2020864received: 2019-10-22accepted: 2020-1-22(C) Wong and Tran,"/>
 <result pre="tetraspanin, Cluster of Differentiation 151 (CD151), is ubiquitously expressed in" exact="adult" post="tissue, especially in the lungs where it has been"/>
 <result pre="especially in the lungs where it has been implicated in" exact="lung cancer," post="asthma, influenza, and idiopathic pulmonary fibrosis (IPF). CD151 interacts"/>
 <result pre="it has been implicated in lung cancer, asthma, influenza, and" exact="idiopathic pulmonary fibrosis" post="(IPF). CD151 interacts with laminin-binding integrins and growth factor"/>
 <result pre="has been implicated in lung cancer, asthma, influenza, and idiopathic" exact="pulmonary" post="fibrosis (IPF). CD151 interacts with laminin-binding integrins and growth"/>
 <result pre="factor receptors, and is reported in cancer-promoting processes such as" exact="tumor" post="initiation, metastasis, and angiogenesis. In asthma, CD151 was shown"/>
 <result pre="was shown to be a novel host factor for nuclear" exact="viral" post="export signaling. Furthermore, CD151 was shown to be associated"/>
 <result pre="signaling. Furthermore, CD151 was shown to be associated with increased" exact="disease" post="severity and poorer survival outcome in asthma and lung"/>
 <result pre="associated with increased disease severity and poorer survival outcome in" exact="asthma" post="and lung cancer, respectively. In this review, we provide"/>
 <result pre="increased disease severity and poorer survival outcome in asthma and" exact="lung cancer," post="respectively. In this review, we provide an update on"/>
 <result pre="for its utility as a screening or prognostic tool in" exact="disease" post="management and/or as a therapeutic target for the treatment"/>
 <result pre="management and/or as a therapeutic target for the treatment of" exact="lung diseases." post="CD151 lung cancer asthma influenza idiopathic pulmonary fibrosis biomarker"/>
 <result pre="a therapeutic target for the treatment of lung diseases. CD151" exact="lung cancer" post="asthma influenza idiopathic pulmonary fibrosis biomarker targeted therapy tetraspanin"/>
 <result pre="therapeutic target for the treatment of lung diseases. CD151 lung" exact="cancer" post="asthma influenza idiopathic pulmonary fibrosis biomarker targeted therapy tetraspanin"/>
 <result pre="target for the treatment of lung diseases. CD151 lung cancer" exact="asthma" post="influenza idiopathic pulmonary fibrosis biomarker targeted therapy tetraspanin Funding"/>
 <result pre="the treatment of lung diseases. CD151 lung cancer asthma influenza" exact="idiopathic pulmonary fibrosis" post="biomarker targeted therapy tetraspanin Funding Ministry of Education -"/>
 <result pre="treatment of lung diseases. CD151 lung cancer asthma influenza idiopathic" exact="pulmonary" post="fibrosis biomarker targeted therapy tetraspanin Funding Ministry of Education"/>
 <result pre="University Health System10.13039/501100011744 fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction" exact="Respiratory" post="diseases account for significant illness and premature mortality around"/>
 <result pre="and premature mortality around the world. The global impact of" exact="respiratory" post="diseases is difficult to quantify due to discrepancies or"/>
 <result pre="ignored. More than 9.5 million deaths globally were attributed to" exact="respiratory" post="diseases â€&quot; the most common of which were asthma,"/>
 <result pre="respiratory diseases â€&quot; the most common of which were asthma," exact="lower" post="respiratory infections, chronic obstructive pulmonary disease, and lung cancer"/>
 <result pre="diseases â€&quot; the most common of which were asthma, lower" exact="respiratory" post="infections, chronic obstructive pulmonary disease, and lung cancer â€&quot;"/>
 <result pre="the most common of which were asthma, lower respiratory infections," exact="chronic" post="obstructive pulmonary disease, and lung cancer â€&quot; and the"/>
 <result pre="common of which were asthma, lower respiratory infections, chronic obstructive" exact="pulmonary" post="disease, and lung cancer â€&quot; and the total cost"/>
 <result pre="were asthma, lower respiratory infections, chronic obstructive pulmonary disease, and" exact="lung cancer" post="â€&quot; and the total cost of respiratory diseases in"/>
 <result pre="asthma, lower respiratory infections, chronic obstructive pulmonary disease, and lung" exact="cancer" post="â€&quot; and the total cost of respiratory diseases in"/>
 <result pre="chronic obstructive pulmonary disease, and lung cancer â€&quot; and the" exact="total" post="cost of respiratory diseases in the European Union alone"/>
 <result pre="disease, and lung cancer â€&quot; and the total cost of" exact="respiratory" post="diseases in the European Union alone was estimated to"/>
 <result pre="respiratory diseases in the European Union alone was estimated to" exact="total" post="over â‚¬380 billion annually (Gibson et al., 2013; Ferkol"/>
 <result pre="agents, and genetics (Gibson et al., 2013) have been identified," exact="respiratory" post="diseases are not curable in some cases and current"/>
 <result pre="treatment options are suboptimal for the majority of patients with" exact="chronic" post="respiratory diseases. Hence, the development of novel therapies is"/>
 <result pre="options are suboptimal for the majority of patients with chronic" exact="respiratory" post="diseases. Hence, the development of novel therapies is required"/>
 <result pre="of novel therapies is required to alter the progression of" exact="disease" post="severity and/or prevent disease onset. In this review, we"/>
 <result pre="required to alter the progression of disease severity and/or prevent" exact="disease" post="onset. In this review, we provide an update on"/>
 <result pre="need to be taken into consideration for its utility in" exact="disease" post="management as a screening or prognostic tool and as"/>
 <result pre="as targeted or adjuvant therapy. FIGURE 1 Contribution of CD151to" exact="respiratory" post="diseases. ASM, airway smooth muscle; IPF, idiopathic pulmonary fibrosis;"/>
 <result pre="Contribution of CD151to respiratory diseases. ASM, airway smooth muscle; IPF," exact="idiopathic pulmonary fibrosis;" post="MMP7, matrix metalloproteinase-7; NSCLC, non-small cell lung cancer. CD151"/>
 <result pre="of CD151to respiratory diseases. ASM, airway smooth muscle; IPF, idiopathic" exact="pulmonary" post="fibrosis; MMP7, matrix metalloproteinase-7; NSCLC, non-small cell lung cancer."/>
 <result pre="IPF, idiopathic pulmonary fibrosis; MMP7, matrix metalloproteinase-7; NSCLC, non-small cell" exact="lung cancer." post="CD151 Cluster of Differentiation 151 was first identified as"/>
 <result pre="named it protein SFA-1 as it was induced by a" exact="T-cell leukemia" post="cell line, SF-HT. The protein was subsequently reassigned as"/>
 <result pre="it protein SFA-1 as it was induced by a T-cell" exact="leukemia" post="cell line, SF-HT. The protein was subsequently reassigned as"/>
 <result pre="also been shown to be associated with CD151 or be" exact="localized" post="within TEMs (Hemler, 2003; Stipp et al., 2003). In"/>
 <result pre="be strongly positive in the lungs, specifically in airway smooth" exact="muscle" post="(Qiao et al., 2017), epithelial layers, endothelial cells and"/>
 <result pre="lungs, specifically in airway smooth muscle (Qiao et al., 2017)," exact="epithelial" post="layers, endothelial cells and blood vessels (Sincock et al.,"/>
 <result pre="muscle (Qiao et al., 2017), epithelial layers, endothelial cells and" exact="blood vessels" post="(Sincock et al., 1997). Given its abundance in lung"/>
 <result pre="mutations resulting in truncated or altered forms of the protein." exact="Nephropathy" post="was reported in four of the cases as well"/>
 <result pre="was reported in four of the cases as well as" exact="epidermolysis bullosa" post="and sensorineural deafness in two cases (Karamatic Crew et"/>
 <result pre="four of the cases as well as epidermolysis bullosa and" exact="sensorineural" post="deafness in two cases (Karamatic Crew et al., 2004;"/>
 <result pre="of the cases as well as epidermolysis bullosa and sensorineural" exact="deafness" post="in two cases (Karamatic Crew et al., 2004; Vahidnezhad"/>
 <result pre="(Karamatic Crew et al., 2008). Differences in lung function or" exact="morphology" post="were not reported in these patients â€&quot; whether genetic"/>
 <result pre="that CD151 is essential for the normal function of alveolar" exact="epithelial" post="cells (APCs) as the deletion of CD151 in APCs"/>
 <result pre="deletion of CD151 in APCs resulted in the loss of" exact="epithelial" post="integrity (loss of epithelial adhesion to the basement membrane)."/>
 <result pre="APCs resulted in the loss of epithelial integrity (loss of" exact="epithelial" post="adhesion to the basement membrane). In addition, there were"/>
 <result pre="mice. The authors concluded that CD151 functions to protect against" exact="pulmonary" post="fibrosis by maintaining epithelial integrity. Besides these reports, findings"/>
 <result pre="that CD151 functions to protect against pulmonary fibrosis by maintaining" exact="epithelial" post="integrity. Besides these reports, findings from other groups may"/>
 <result pre="CD151. Treatment with anti-CD151 antibody resulted in the loss of" exact="epithelial" post="integrity in skin epithelial cells (Shigeta et al., 2003)"/>
 <result pre="antibody resulted in the loss of epithelial integrity in skin" exact="epithelial" post="cells (Shigeta et al., 2003) whilst CD151 knockdown was"/>
 <result pre="observed are a direct consequence of CD151 dysregulation or a" exact="secondary" post="effect of CD151 due to disruption of its laminin-binding"/>
 <result pre="effect of CD151 due to disruption of its laminin-binding partners." exact="Tumor" post="Promoter in Lung Cancer Lung cancer has a high"/>
 <result pre="to disruption of its laminin-binding partners. Tumor Promoter in Lung" exact="Cancer" post="Lung cancer has a high degree of molecular heterogeneity"/>
 <result pre="disruption of its laminin-binding partners. Tumor Promoter in Lung Cancer" exact="Lung cancer" post="has a high degree of molecular heterogeneity thus giving"/>
 <result pre="of its laminin-binding partners. Tumor Promoter in Lung Cancer Lung" exact="cancer" post="has a high degree of molecular heterogeneity thus giving"/>
 <result pre="characteristics leading to the distinction between small and non-small cell" exact="lung cancer" post="(NSCLC) (Herbst et al., 2008). The onslaught of molecular"/>
 <result pre="leading to the distinction between small and non-small cell lung" exact="cancer" post="(NSCLC) (Herbst et al., 2008). The onslaught of molecular"/>
 <result pre="et al., 2017; Herbst et al., 2018). The pathogenesis of" exact="lung cancer" post="and its management has been covered extensively by others"/>
 <result pre="al., 2017; Herbst et al., 2018). The pathogenesis of lung" exact="cancer" post="and its management has been covered extensively by others"/>
 <result pre="CD151 was the first tetraspanin to be identified as a" exact="tumor" post="promoter (Testa et al., 1999). The authors found that"/>
 <result pre="against CD151 was capable of inhibiting both spontaneous and experimental" exact="metastasis" post="in the chick embryo chorioallantoic membrane model. Since then,"/>
 <result pre="al., 2012; Kang et al., 2013; Romanska et al., 2013;" exact="Fisher" post="et al., 2016; Medrano et al., 2017). In NSCLC,"/>
 <result pre="et al., 2013). Exosome protein profiling comparing a cohort of" exact="lung cancer" post="patients with non-cancer patients revealed that CD151 was one"/>
 <result pre="al., 2013). Exosome protein profiling comparing a cohort of lung" exact="cancer" post="patients with non-cancer patients revealed that CD151 was one"/>
 <result pre="was one of the markers found to be upregulated in" exact="lung cancer" post="(Sandfeld-Paulsen et al., 2016). This study showed that whilst"/>
 <result pre="one of the markers found to be upregulated in lung" exact="cancer" post="(Sandfeld-Paulsen et al., 2016). This study showed that whilst"/>
 <result pre="exosomes in circulation to act as components for crosstalk between" exact="cancer" post="initiating cells and their environment (Yue et al., 2015)."/>
 <result pre="(Yue et al., 2015). This highlights their key role in" exact="cancer" post="and as a mediator of cell-cell communication. Use of"/>
 <result pre="been employed to explore the functional significance of CD151. In" exact="lung cancer" post="cells, CD151 knockdown resulted in impairment of several cancer-promoting"/>
 <result pre="employed to explore the functional significance of CD151. In lung" exact="cancer" post="cells, CD151 knockdown resulted in impairment of several cancer-promoting"/>
 <result pre="such as integrin Î±3Î²1 (Yamada et al., 2008), matrix metalloproteinase-9," exact="vascular" post="endothelial growth factor (Li et al., 2015) and hepatocyte"/>
 <result pre="and subsequently downstream signaling of these proteins. In spontaneous lung" exact="metastasis" post="models, CD151-null mice exhibited a marked delay in tumor"/>
 <result pre="lung metastasis models, CD151-null mice exhibited a marked delay in" exact="tumor" post="initiation and a decrease in number of metastastic lesions"/>
 <result pre="(Deng et al., 2012; Copeland et al., 2013). Similarly, when" exact="tumor" post="cells were injected at a separate primary site, CD151-null"/>
 <result pre="2013). Similarly, when tumor cells were injected at a separate" exact="primary" post="site, CD151-null mice also showed reduced lung metastasis and"/>
 <result pre="a separate primary site, CD151-null mice also showed reduced lung" exact="metastasis" post="and tumor cell residence (Takeda et al., 2007, 2011;"/>
 <result pre="primary site, CD151-null mice also showed reduced lung metastasis and" exact="tumor" post="cell residence (Takeda et al., 2007, 2011; Sadej et"/>
 <result pre="al., 2007, 2011; Sadej et al., 2010). Hyperresponsiveness Mediator in" exact="Asthma" post="Asthma is a chronic airway disease characterized by three"/>
 <result pre="2007, 2011; Sadej et al., 2010). Hyperresponsiveness Mediator in Asthma" exact="Asthma" post="is a chronic airway disease characterized by three main"/>
 <result pre="et al., 2010). Hyperresponsiveness Mediator in Asthma Asthma is a" exact="chronic" post="airway disease characterized by three main features, airways hyperresponsiveness,"/>
 <result pre="2010). Hyperresponsiveness Mediator in Asthma Asthma is a chronic airway" exact="disease" post="characterized by three main features, airways hyperresponsiveness, airway wall"/>
 <result pre="and airway inflammation (Barnes, 1996; Kudo et al., 2013). Current" exact="asthma" post="treatment is mainly focused on long-term clinical control of"/>
 <result pre="asthma treatment is mainly focused on long-term clinical control of" exact="asthma" post="and rapid-acting symptom relief. However, these drugs are suboptimal"/>
 <result pre="the case of the widely prescribed inhaled corticosteroids which are" exact="limited" post="in its clinical efficacy due to varying responsiveness in"/>
 <result pre="al., 2015). Therefore, a better understanding of underlying mechanisms of" exact="disease" post="and therapeutic targeting of these mechanisms may contribute greatly"/>
 <result pre="therapeutic targeting of these mechanisms may contribute greatly to improved" exact="asthma" post="management. Expression of CD51 is clinically relevant to asthma"/>
 <result pre="improved asthma management. Expression of CD51 is clinically relevant to" exact="asthma" post="as immunohistochemical analysis of human bronchial biopsy specimens for"/>
 <result pre="human bronchial biopsy specimens for CD151 expression in airway smooth" exact="muscle" post="bundles were highest in mild or moderate asthma subjects"/>
 <result pre="airway smooth muscle bundles were highest in mild or moderate" exact="asthma" post="subjects compared with non-asthmatic subjects (Qiao et al., 2017)."/>
 <result pre="signaling, which are key signaling pathways implicated in airway smooth" exact="muscle" post="cell contraction. In support, CD151-null mice did not exhibit"/>
 <result pre="determined is whether high CD151 expression is a result of" exact="asthma" post="or whether elevated expression of CD151 results in asthma."/>
 <result pre="inflammation, is yet to be established. Host Factor in Influenza" exact="Viral" post="Export An estimated 5% of adults develop influenza symptoms"/>
 <result pre="symptoms annually with severe cases leading to conditions such as" exact="bronchitis" post="and pneumonia. These seasonal epidemics are largely due to"/>
 <result pre="containing the surface glycoproteins hemagglutinin and neuraminidase â€&quot; involved in" exact="viral" post="entry and progeny release, respectively (Nicholson et al., 2003;"/>
 <result pre="Spriel and Figdor, 2010). CD151 was previously implicated in several" exact="viral" post="infections including papillomavirus, cytomegalovirus and human immunodeficiency virus (Thali,"/>
 <result pre="and Figdor, 2010). CD151 was previously implicated in several viral" exact="infections" post="including papillomavirus, cytomegalovirus and human immunodeficiency virus (Thali, 2011;"/>
 <result pre="implicated in several viral infections including papillomavirus, cytomegalovirus and human" exact="immunodeficiency" post="virus (Thali, 2011; Scheffer et al., 2014; Hochdorfer et"/>
 <result pre="al., 2018). The knockdown of CD151 expression in patient-derived nasal" exact="epithelial" post="cells resulted in a significant reduction in IAV progeny"/>
 <result pre="epithelial cells resulted in a significant reduction in IAV progeny" exact="viral" post="load. In addition, CD151-null mice were more resistant and"/>
 <result pre="addition, CD151-null mice were more resistant and tolerant to IAV" exact="infection" post="with higher survival rates as compared to the wild-type"/>
 <result pre="as compared to the wild-type infected mice. With regards to" exact="respiratory" post="infection, the anti-viral responses were attributed to CD151 mediating"/>
 <result pre="export of progeny viruses through its binding to newly synthesized" exact="viral" post="proteins (NP, M1, and NEP) and host nuclear export"/>
 <result pre="nuclear export protein (CRM1). The novel action of CD151 on" exact="viral" post="nuclear export signaling associated with H3N2 and H1N1 infection"/>
 <result pre="on viral nuclear export signaling associated with H3N2 and H1N1" exact="infection" post="(Qiao et al., 2018) highlights the potential of CD151"/>
 <result pre="developed as a novel therapy to treat influenza and other" exact="viral" post="infections. Targeting CD151 is especially beneficial given that it"/>
 <result pre="mechanism thus making it less susceptible to constant changes in" exact="viral" post="strains â€&quot; due to antigenic shift and antigenic drift"/>
 <result pre="antiviral drugs or vaccines ineffective after each season. Protective or" exact="Progressive" post="Role in Idiopathic Pulmonary Fibrosis Idiopathic pulmonary fibrosis (IPF)"/>
 <result pre="vaccines ineffective after each season. Protective or Progressive Role in" exact="Idiopathic" post="Pulmonary Fibrosis Idiopathic pulmonary fibrosis (IPF) is a form"/>
 <result pre="ineffective after each season. Protective or Progressive Role in Idiopathic" exact="Pulmonary" post="Fibrosis Idiopathic pulmonary fibrosis (IPF) is a form of"/>
 <result pre="each season. Protective or Progressive Role in Idiopathic Pulmonary Fibrosis" exact="Idiopathic pulmonary fibrosis" post="(IPF) is a form of interstitial pneumonia that features"/>
 <result pre="season. Protective or Progressive Role in Idiopathic Pulmonary Fibrosis Idiopathic" exact="pulmonary" post="fibrosis (IPF) is a form of interstitial pneumonia that"/>
 <result pre="Fibrosis Idiopathic pulmonary fibrosis (IPF) is a form of interstitial" exact="pneumonia" post="that features the chronic and progressive scarring of the"/>
 <result pre="(IPF) is a form of interstitial pneumonia that features the" exact="chronic" post="and progressive scarring of the lung. Initially regarded as"/>
 <result pre="2017; Mora et al., 2017). Interestingly, CD151-null mice spontaneously developed" exact="pulmonary" post="fibrosis features observed at 30 weeks and exhibited accelerated"/>
 <result pre="30 weeks and exhibited accelerated bleomycin-induced lung injury in the" exact="pulmonary" post="fibrosis model, suggesting a protective role of CD151 in"/>
 <result pre="CD151-null mice is strain-specific as differences in renal function in" exact="tumor" post="formation (Li et al., 2013) has been observed between"/>
 <result pre="CD151 has been implicated in other fibrotic processes, such as" exact="liver fibrosis" post="and skin wound healing (Mazzocca et al., 2002; Geary"/>
 <result pre="Expression CD151 Expression Modulators Given the importance of CD151 in" exact="respiratory" post="diseases, it is interesting to note that little is"/>
 <result pre="The study conducted by Hua et al. (2001) showed that" exact="chronic" post="administration of the anti-epileptic drugs, carbamazepine or valproate, significantly"/>
 <result pre="significantly decreased CD151 transcript levels in rat frontal cortex following" exact="chronic" post="(five-week) treatment. The functional significance of this reduction was"/>
 <result pre="camptothecin, and 5-fluorouracil) induced CD151 protein levels in A431 skin" exact="epidermoid carcinoma" post="cells. They further showed that gefitinib upregulated CD151 protein"/>
 <result pre="and 5-fluorouracil) induced CD151 protein levels in A431 skin epidermoid" exact="carcinoma" post="cells. They further showed that gefitinib upregulated CD151 protein"/>
 <result pre="further showed that gefitinib upregulated CD151 protein levels in MDA-MB-231" exact="breast" post="and A549 lung carcinoma cell lines, respectively. In this"/>
 <result pre="gefitinib upregulated CD151 protein levels in MDA-MB-231 breast and A549" exact="lung carcinoma" post="cell lines, respectively. In this study, the group showed"/>
 <result pre="upregulated CD151 protein levels in MDA-MB-231 breast and A549 lung" exact="carcinoma" post="cell lines, respectively. In this study, the group showed"/>
 <result pre="cell adhesion and metastasis. Hypoxia is the condition of oxygen" exact="deficiency" post="and is a major driver of cancer-promoting processes such"/>
 <result pre="whether the same hypoxic conditions can reduce CD151 in a" exact="lung cancer" post="setting. Mechanisms Underlying CD151 Regulation Whilst CD151 expression modulation"/>
 <result pre="the same hypoxic conditions can reduce CD151 in a lung" exact="cancer" post="setting. Mechanisms Underlying CD151 Regulation Whilst CD151 expression modulation"/>
 <result pre="Whilst CD151 expression modulation plays a critical role in determining" exact="disease" post="progression, whether in promoting pathophysiology of lung cancer, asthma,"/>
 <result pre="role in determining disease progression, whether in promoting pathophysiology of" exact="lung cancer," post="asthma, and influenza or in potentially protecting against IPF,"/>
 <result pre="intron II, suggesting a direct action on CD151 regulation by" exact="hypoxia" post="exposure. In addition to transcriptional regulation of CD151 expression,"/>
 <result pre="protein stability. Key Considerations for CD151 in the Management of" exact="Lung Diseases" post="CD151 as a Prognostic and Diagnostic Tool The prognostic"/>
 <result pre="stability. Key Considerations for CD151 in the Management of Lung" exact="Diseases" post="CD151 as a Prognostic and Diagnostic Tool The prognostic"/>
 <result pre="The prognostic value of CD151 was previously emphasized in low-grade" exact="prostate cancer," post="in which CD151 expression could predict the clinical outcome"/>
 <result pre="et al., 2004). Given the strong association between CD151 and" exact="lung cancer" post="(Tokuhara et al., 2001; Kwon et al., 2013), especially"/>
 <result pre="al., 2004). Given the strong association between CD151 and lung" exact="cancer" post="(Tokuhara et al., 2001; Kwon et al., 2013), especially"/>
 <result pre="cancer (Tokuhara et al., 2001; Kwon et al., 2013), especially" exact="adenocarcinoma" post="which is the most common NSCLC subtype, CD151 expression"/>
 <result pre="et al., 2013), especially adenocarcinoma which is the most common" exact="NSCLC" post="subtype, CD151 expression has proven to be especially informative"/>
 <result pre="asthma, in which the expression of CD151 was associated with" exact="disease" post="severity (Qiao et al., 2017). Besides immunohistochemical analysis, an"/>
 <result pre="explored where a high level of accuracy (72%) in detecting" exact="cancer" post="in adenocarcinoma patients was observed (Sandfeld-Paulsen et al., 2016)."/>
 <result pre="a high level of accuracy (72%) in detecting cancer in" exact="adenocarcinoma" post="patients was observed (Sandfeld-Paulsen et al., 2016). Effective screening"/>
 <result pre="et al., 2016). Effective screening methods are especially vital in" exact="NSCLC" post="for which 60% of patients are only diagnosed at"/>
 <result pre="of CD151 in a milieu of processes that contribute to" exact="lung disease" post="pathophysiology, targeting CD151 in a clinical setting is justifiable."/>
 <result pre="CD151 in a milieu of processes that contribute to lung" exact="disease" post="pathophysiology, targeting CD151 in a clinical setting is justifiable."/>
 <result pre="antibodies has been shown to impair cellular processes at multiple" exact="cancer" post="stages. Tumor growth potential, neoangiogenesis and metastasis following injection"/>
 <result pre="been shown to impair cellular processes at multiple cancer stages." exact="Tumor" post="growth potential, neoangiogenesis and metastasis following injection with a"/>
 <result pre="processes at multiple cancer stages. Tumor growth potential, neoangiogenesis and" exact="metastasis" post="following injection with a hepatocellular carcinoma cell line was"/>
 <result pre="Tumor growth potential, neoangiogenesis and metastasis following injection with a" exact="hepatocellular carcinoma" post="cell line was also inhibited in mice that were"/>
 <result pre="growth potential, neoangiogenesis and metastasis following injection with a hepatocellular" exact="carcinoma" post="cell line was also inhibited in mice that were"/>
 <result pre="experimental metastasis. Similarly, the mAb SFA1.2B4 was shown to impair" exact="pulmonary" post="metastasis in mice injected with either colon cancer or"/>
 <result pre="metastasis. Similarly, the mAb SFA1.2B4 was shown to impair pulmonary" exact="metastasis" post="in mice injected with either colon cancer or fibrosarcoma"/>
 <result pre="shown to impair pulmonary metastasis in mice injected with either" exact="colon cancer" post="or fibrosarcoma cell lines (Kohno et al., 2002). Whether"/>
 <result pre="to impair pulmonary metastasis in mice injected with either colon" exact="cancer" post="or fibrosarcoma cell lines (Kohno et al., 2002). Whether"/>
 <result pre="pulmonary metastasis in mice injected with either colon cancer or" exact="fibrosarcoma" post="cell lines (Kohno et al., 2002). Whether or not"/>
 <result pre="et al., 2002). Whether or not these monoclonal antibodies disrupt" exact="disease" post="progression in respiratory diseases remain to be explored, although"/>
 <result pre="Whether or not these monoclonal antibodies disrupt disease progression in" exact="respiratory" post="diseases remain to be explored, although its anti-cancer properties"/>
 <result pre="be explored, although its anti-cancer properties for the treatment of" exact="lung cancer" post="are promising. Besides the use of monoclonal antibodies, CD151"/>
 <result pre="explored, although its anti-cancer properties for the treatment of lung" exact="cancer" post="are promising. Besides the use of monoclonal antibodies, CD151"/>
 <result pre="CD151 gene deletion has been instrumental in improving markers of" exact="disease" post="outcomes in asthma, influenza, and tumor progression. As described"/>
 <result pre="in improving markers of disease outcomes in asthma, influenza, and" exact="tumor" post="progression. As described above, CD151 knockdown, through siRNA technology,"/>
 <result pre="above, CD151 knockdown, through siRNA technology, markedly reduced airway smooth" exact="muscle" post="contraction whilst airway hyperresponsive processes decreased significantly in allergen-induced"/>
 <result pre="processes decreased significantly in allergen-induced CD151-null mice. Following influenza A" exact="virus infection," post="CD151-null mice exhibited better survival and reduced viral titer,"/>
 <result pre="A virus infection, CD151-null mice exhibited better survival and reduced" exact="viral" post="titer, which was attributed to the role of CD151"/>
 <result pre="attributed to the role of CD151 in nuclear export of" exact="viral" post="proteins confirmed using CD151 knockdown experiments. In the context"/>
 <result pre="knockdown experiments. In the context of cancer, both experimental lung" exact="metastasis" post="and tumor cell residence were reduced in CD151-null mice."/>
 <result pre="In the context of cancer, both experimental lung metastasis and" exact="tumor" post="cell residence were reduced in CD151-null mice. Furthermore, pathologic"/>
 <result pre="angiogenesis was impaired in these CD151-null mice despite showing no" exact="vascular" post="defects under normal developmental conditions. The impact of CD151"/>
 <result pre="developmental conditions. The impact of CD151 was also reported in" exact="breast cancer" post="in which mammary tumor initiation, tumor growth, survival, and"/>
 <result pre="conditions. The impact of CD151 was also reported in breast" exact="cancer" post="in which mammary tumor initiation, tumor growth, survival, and"/>
 <result pre="CD151 was also reported in breast cancer in which mammary" exact="tumor" post="initiation, tumor growth, survival, and metastasis were impaired in"/>
 <result pre="also reported in breast cancer in which mammary tumor initiation," exact="tumor" post="growth, survival, and metastasis were impaired in CD151-null mice"/>
 <result pre="cancer in which mammary tumor initiation, tumor growth, survival, and" exact="metastasis" post="were impaired in CD151-null mice (Yang et al., 2008;"/>
 <result pre="provide another avenue for exploiting the importance of CD151 in" exact="lung diseases." post="Several reviews have summarized the clinical significance of nanomedicine"/>
 <result pre="to hepatic myofibroblasts was more effective and well-tolerated compared to" exact="systemic" post="administration of the drug alone (Deshmukh et al., 2018)."/>
 <result pre="be explored given the importance of CD151 overexpression in various" exact="lung diseases" post="and other human malignancies. Delivery of genetic material to"/>
 <result pre="the expression of CD151, such as in the case of" exact="short" post="hairpin RNA or guide RNA for CRISPR/Cas9-based genome editing,"/>
 <result pre="as route of drug administration (local delivery via inhalation versus" exact="systemic" post="delivery) (Yan et al., 2016; Cryer and Thorley, 2019;"/>
 <result pre="taken into account given the importance of expression changes in" exact="disease" post="progression and severity. Cluster of Differentiation 151 may also"/>
 <result pre="was shown to impair growth factor receptor-dependent processes such as" exact="tumor" post="onset, cell growth, spreading and motility. CD151 ablation in"/>
 <result pre="processes. Therefore, it has been implicated in several diseases, including" exact="respiratory" post="diseases such as lung cancer, asthma, influenza and IPF"/>
 <result pre="been implicated in several diseases, including respiratory diseases such as" exact="lung cancer," post="asthma, influenza and IPF (Figure 1). The majority of"/>
 <result pre="IPF (Figure 1). The majority of studies link CD151 to" exact="disease" post="onset, severity or progression. The mechanisms underlying CD151 upregulation"/>
 <result pre="or as a prognostic biomarker given its relevance in predicting" exact="lung cancer" post="or asthma severity. Furthermore, CD151 monoclonal antibodies, gene deletion,"/>
 <result pre="as a prognostic biomarker given its relevance in predicting lung" exact="cancer" post="or asthma severity. Furthermore, CD151 monoclonal antibodies, gene deletion,"/>
 <result pre="prognostic biomarker given its relevance in predicting lung cancer or" exact="asthma" post="severity. Furthermore, CD151 monoclonal antibodies, gene deletion, and nanotechnology"/>
 <result pre="a novel targeted or adjuvant therapy in the treatment of" exact="respiratory" post="diseases. Author Contributions AW and TT wrote and edited"/>
 <result pre="The authors declare that the research was conducted in the" exact="absence of" post="any commercial or financial relationships that could be construed"/>
 <result pre="(2004). CD151 protein expression predicts the clinical outcome of low-grade" exact="primary" post="prostate cancer better than histologic grading: a new prognostic"/>
 <result pre="CD151 protein expression predicts the clinical outcome of low-grade primary" exact="prostate cancer" post="better than histologic grading: a new prognostic indicator?Cancer Epidemiol."/>
 <result pre="protein expression predicts the clinical outcome of low-grade primary prostate" exact="cancer" post="better than histologic grading: a new prognostic indicator?Cancer Epidemiol."/>
 <result pre="D.HurdS. S.BarnesP. J.BousquetJ.DrazenJ. M.FitzgeraldJ. M.et al. (2008). Global strategy for" exact="asthma" post="management and prevention: GINA executive summary.Eur. Respir. J.31143â€&quot;178. 10.1183/09031936.0013870718166595"/>
 <result pre="C.LaiY. Y.LinB. W.LeeJ. C.TsaiS. J. (2008). Regulation of CD151 by" exact="hypoxia" post="controls cell adhesion and metastasis in colorectal cancer.Clin. Cancer"/>
 <result pre="(2008). Regulation of CD151 by hypoxia controls cell adhesion and" exact="metastasis" post="in colorectal cancer.Clin. Cancer Res.148043â€&quot;8051. 10.1158/1078-0432.CCR-08-165119073968 CopelandB. T.BowmanM. J.AshmanL."/>
 <result pre="by hypoxia controls cell adhesion and metastasis in colorectal cancer.Clin." exact="Cancer" post="Res.148043â€&quot;8051. 10.1158/1078-0432.CCR-08-165119073968 CopelandB. T.BowmanM. J.AshmanL. K. (2013). Genetic ablation"/>
 <result pre="K. (2013). Genetic ablation of the tetraspanin CD151 reduces spontaneous" exact="metastatic" post="spread of prostate cancer in the TRAMP model.Mol. Cancer"/>
 <result pre="ablation of the tetraspanin CD151 reduces spontaneous metastatic spread of" exact="prostate cancer" post="in the TRAMP model.Mol. Cancer Res.1195â€&quot;105. 10.1158/1541-7786.MCR-12-046823131993 CryerA. M.ThorleyA."/>
 <result pre="of the tetraspanin CD151 reduces spontaneous metastatic spread of prostate" exact="cancer" post="in the TRAMP model.Mol. Cancer Res.1195â€&quot;105. 10.1158/1541-7786.MCR-12-046823131993 CryerA. M.ThorleyA."/>
 <result pre="spontaneous metastatic spread of prostate cancer in the TRAMP model.Mol." exact="Cancer" post="Res.1195â€&quot;105. 10.1158/1541-7786.MCR-12-046823131993 CryerA. M.ThorleyA. J. (2019). Nanotechnology in the"/>
 <result pre="Ther.198189â€&quot;205. 10.1016/j.pharmthera.2019.02.01030796927 DengX.LiQ.HoffJ.NovakM.YangH.JinH.et al. (2012). Integrin-associated CD151 drives ErbB2-evoked mammary" exact="tumor" post="onset and metastasis.Neoplasia14678â€&quot;689. 22952421 DeshmukhM.NakagawaS.HigashiT.VincekA.VenkateshA.Ruiz De GalarretaM.et al. (2018)."/>
 <result pre="De GalarretaM.et al. (2018). Cell type-specific pharmacological kinase inhibition for" exact="cancer" post="chemoprevention.Nanomedicine14317â€&quot;325. 10.1016/j.nano.2017.11.00429157977 FerkolT.SchraufnagelD. (2014). The global burden of respiratory"/>
 <result pre="for cancer chemoprevention.Nanomedicine14317â€&quot;325. 10.1016/j.nano.2017.11.00429157977 FerkolT.SchraufnagelD. (2014). The global burden of" exact="respiratory" post="disease.Ann. Am. Thorac. Soc.11404â€&quot;406. 10.1513/AnnalsATS.201311-405PS24673696 FisherO. M.Levert-MignonA. J.LehaneC. W.BotelhoN."/>
 <result pre="and protein expression provides independent prognostic information for patients with" exact="adenocarcinoma" post="of the esophagus and gastroesophageal junction treated by esophagectomy.Ann."/>
 <result pre="provides independent prognostic information for patients with adenocarcinoma of the" exact="esophagus" post="and gastroesophageal junction treated by esophagectomy.Ann. Surg. Oncol.23746â€&quot;754. 10.1245/s10434-016-5504-927577713"/>
 <result pre="(2010). The tetraspanin CD151 is required for Met-dependent signaling and" exact="tumor" post="cell growth.J. Biol. Chem.28538756â€&quot;38764. 10.1074/jbc.M110.14541720937830 FujishimaS.ShiomiT.YamashitaS.YogoY.NakanoY.InoueT.et al. (2010). Production"/>
 <result pre="7 (matrilysin 1) in the lungs of patients with idiopathic" exact="pulmonary" post="fibrosis.Arch. Pathol. Lab. Med.1341136â€&quot;1142. 10.1043/2009-0144-OA.120670133 GearyS. M.CowinA. J.CopelandB.BaleatoR. M.MiyazakiK.AshmanL."/>
 <result pre="M.MiyazakiK.AshmanL. K. (2008). The role of the tetraspanin CD151 in" exact="primary" post="keratinocyte and fibroblast functions: implications for wound healing.Exp. Cell"/>
 <result pre="implications for wound healing.Exp. Cell Res.3142165â€&quot;2175. 10.1016/j.yexcr.2008.04.01118534576 GibsonG. J.LoddenkemperR.LundbackB.SibilleY. (2013)." exact="Respiratory" post="health and disease in Europe: the new European lung"/>
 <result pre="healing.Exp. Cell Res.3142165â€&quot;2175. 10.1016/j.yexcr.2008.04.01118534576 GibsonG. J.LoddenkemperR.LundbackB.SibilleY. (2013). Respiratory health and" exact="disease" post="in Europe: the new European lung white book.Eur. Respir."/>
 <result pre="mood stabilizing drugs?Neuropsychopharmacology25729â€&quot;736. 10.1016/s0893-133x(01)00269-x11682256 HwangS.TakimotoT.HemlerM. E. (2019). Integrin-independent support of" exact="cancer" post="drug resistance by tetraspanin CD151.Cell. Mol. Life Sci.761595â€&quot;1604. 10.1007/s00018-019-03014-730778617"/>
 <result pre="expression associated with prognosis for patients with advanced gastric cancer.J." exact="Cancer" post="Res. Clin. Oncol.1391835â€&quot;1843. 10.1007/s00432-013-1503-424005419 Karamatic CrewV.BurtonN.KaganA.GreenC. A.LeveneC.FlinterF.et al. (2004)."/>
 <result pre="KeQ.CostaM. (2006). Hypoxia-inducible factor-1 (HIF-1).Mol. Pharmacol.701469â€&quot;1480. 16887934 KingT. E.Jr.PardoA.SelmanM. (2011)." exact="Idiopathic" post="pulmonary fibrosis.Lancet3781949â€&quot;1961. 10.1016/S0140-6736(11)60052-421719092 KlibanovA. L.MaruyamaK.TorchilinV. P.HuangL. (1990). Amphipathic polyethyleneglycols"/>
 <result pre="(2006). Hypoxia-inducible factor-1 (HIF-1).Mol. Pharmacol.701469â€&quot;1480. 16887934 KingT. E.Jr.PardoA.SelmanM. (2011). Idiopathic" exact="pulmonary" post="fibrosis.Lancet3781949â€&quot;1961. 10.1016/S0140-6736(11)60052-421719092 KlibanovA. L.MaruyamaK.TorchilinV. P.HuangL. (1990). Amphipathic polyethyleneglycols effectively"/>
 <result pre="(2005). CD151 forms a functional complex with c-Met in human" exact="salivary gland" post="cancer cells.Biochem. Biophys. Res. Commun.336408â€&quot;416. 10.1016/j.bbrc.2005.08.10616139245 KohnoM.HasegawaH.MiyakeM.YamamotoT.FujitaS. (2002). CD151"/>
 <result pre="forms a functional complex with c-Met in human salivary gland" exact="cancer" post="cells.Biochem. Biophys. Res. Commun.336408â€&quot;416. 10.1016/j.bbrc.2005.08.10616139245 KohnoM.HasegawaH.MiyakeM.YamamotoT.FujitaS. (2002). CD151 enhances"/>
 <result pre="Res. Commun.336408â€&quot;416. 10.1016/j.bbrc.2005.08.10616139245 KohnoM.HasegawaH.MiyakeM.YamamotoT.FujitaS. (2002). CD151 enhances cell motility and" exact="metastasis" post="of cancer cells in the presence of focal adhesion"/>
 <result pre="10.1016/j.bbrc.2005.08.10616139245 KohnoM.HasegawaH.MiyakeM.YamamotoT.FujitaS. (2002). CD151 enhances cell motility and metastasis of" exact="cancer" post="cells in the presence of focal adhesion kinase.Int. J."/>
 <result pre="motility and metastasis of cancer cells in the presence of" exact="focal" post="adhesion kinase.Int. J. Cancer97336â€&quot;343. 10.1002/ijc.160511774285 KreidbergJ. A.DonovanM. J.GoldsteinS. L.RennkeH.ShepherdK.JonesR."/>
 <result pre="J. Cancer97336â€&quot;343. 10.1002/ijc.160511774285 KreidbergJ. A.DonovanM. J.GoldsteinS. L.RennkeH.ShepherdK.JonesR. C.et al. (1996)." exact="Alpha" post="3 beta 1 integrin has a crucial role in"/>
 <result pre="(2012). Clinical significance of CD151 overexpression in subtypes of invasive" exact="breast" post="cancer.Br. J. Cancer106923â€&quot;930. 10.1038/bjc.2012.1122294188 KwonM. J.SeoJ.KimY. J.ChoiJ. Y.KimT. E.LeeD."/>
 <result pre="al. (2015). Effects of tetraspanin CD151 inhibition on A549 human" exact="lung adenocarcinoma" post="cells.Mol. Med. Rep.111258â€&quot;1265. 10.3892/mmr.2014.277425351816 LiQ.YangX. H.XuF.SharmaC.WangH. X.KnoblichK.et al. (2013)."/>
 <result pre="(2015). Effects of tetraspanin CD151 inhibition on A549 human lung" exact="adenocarcinoma" post="cells.Mol. Med. Rep.111258â€&quot;1265. 10.3892/mmr.2014.277425351816 LiQ.YangX. H.XuF.SharmaC.WangH. X.KnoblichK.et al. (2013)."/>
 <result pre="al. (2013). Tetraspanin CD151 plays a key role in skin" exact="squamous cell" post="carcinoma.Oncogene321772â€&quot;1783. 10.1038/onc.2012.20522824799 LiuL.HeB.LiuW. M.ZhouD.CoxJ. V.ZhangX. A. (2007). Tetraspanin CD151"/>
 <result pre="integrin trafficking.J. Biol. Chem.28231631â€&quot;31642. 10.1074/jbc.m70116520017716972 MartinezF. J.CollardH. R.PardoA.RaghuG.RicheldiL.SelmanM.et al. (2017)." exact="Idiopathic" post="pulmonary fibrosis.Nat. Rev. Dis. Primers3:17074. 10.1038/nrdp.2017.7429052582 MatsumuraY.MaedaH. (1986). A"/>
 <result pre="trafficking.J. Biol. Chem.28231631â€&quot;31642. 10.1074/jbc.m70116520017716972 MartinezF. J.CollardH. R.PardoA.RaghuG.RicheldiL.SelmanM.et al. (2017). Idiopathic" exact="pulmonary" post="fibrosis.Nat. Rev. Dis. Primers3:17074. 10.1038/nrdp.2017.7429052582 MatsumuraY.MaedaH. (1986). A new"/>
 <result pre="10.1038/nrdp.2017.7429052582 MatsumuraY.MaedaH. (1986). A new concept for macromolecular therapeutics in" exact="cancer" post="chemotherapy: mechanism of tumoritropic accumulation of proteins and the"/>
 <result pre="Interrogation of functional cell-surface markers identifies cd151 dependency in high-grade" exact="serous" post="ovarian cancer.Cell Rep.182343â€&quot;2358. 10.1016/j.celrep.2017.02.02828273451 MerinoA. M.HoogduijnM. J.BorrasF. E.FranquesaM. (2014)."/>
 <result pre="extracellular vesicles.Front. Immunol.5:658. 10.3389/fimmu.2014.0065825566267 MoraA. L.RojasM.PardoA.SelmanM. (2017). Emerging therapies for" exact="idiopathic pulmonary fibrosis," post="a progressive age-related disease.Nat. Rev. Drug Discov.16755â€&quot;772. 10.1038/nrd.2017.17028983101 MukherjeeA.PaulM.MukherjeeS."/>
 <result pre="vesicles.Front. Immunol.5:658. 10.3389/fimmu.2014.0065825566267 MoraA. L.RojasM.PardoA.SelmanM. (2017). Emerging therapies for idiopathic" exact="pulmonary" post="fibrosis, a progressive age-related disease.Nat. Rev. Drug Discov.16755â€&quot;772. 10.1038/nrd.2017.17028983101"/>
 <result pre="Laminin alpha 5 is required for lobar septation and visceral" exact="pleural" post="basement membrane formation in the developing mouse lung.Dev. Biol.246231â€&quot;244."/>
 <result pre="A summary of the new GINA strategy: a roadmap to" exact="asthma" post="control.Eur. Respir. J.46622â€&quot;639. 10.1183/13993003.00853-201526206872 RicheldiL.CollardH. R.JonesM. G. (2017). Idiopathic"/>
 <result pre="to asthma control.Eur. Respir. J.46622â€&quot;639. 10.1183/13993003.00853-201526206872 RicheldiL.CollardH. R.JonesM. G. (2017)." exact="Idiopathic" post="pulmonary fibrosis.Lancet3891941â€&quot;1952. 10.1016/S0140-6736(17)30866-828365056 RomanskaH. M.PotemskiP.CollinsS. I.WilliamsH.ParmarS.BerditchevskiF. (2013). Loss of"/>
 <result pre="asthma control.Eur. Respir. J.46622â€&quot;639. 10.1183/13993003.00853-201526206872 RicheldiL.CollardH. R.JonesM. G. (2017). Idiopathic" exact="pulmonary" post="fibrosis.Lancet3891941â€&quot;1952. 10.1016/S0140-6736(17)30866-828365056 RomanskaH. M.PotemskiP.CollinsS. I.WilliamsH.ParmarS.BerditchevskiF. (2013). Loss of CD151/Tspan24"/>
 <result pre="tumour is a negative predictor of disease-free survival in oral" exact="squamous cell" post="carcinoma.Oral Oncol.49224â€&quot;229. 10.1016/j.oraloncology.2012.09.01323099281 RomanskaH. M.PotemskiP.KrakowskaM.MieszkowskaM.ChaudhriS.KordekR.et al. (2015). Lack of"/>
 <result pre="CD151/integrin alpha3beta1 complex is predictive of poor outcome in node-negative" exact="lobular" post="breast carcinoma: opposing roles of CD151 in invasive lobular"/>
 <result pre="alpha3beta1 complex is predictive of poor outcome in node-negative lobular" exact="breast" post="carcinoma: opposing roles of CD151 in invasive lobular and"/>
 <result pre="node-negative lobular breast carcinoma: opposing roles of CD151 in invasive" exact="lobular" post="and ductal breast cancers.Br. J. Cancer1131350â€&quot;1357. 10.1038/bjc.2015.34426418423 RosenblumD.JoshiN.TaoW.KarpJ. M.PeerD."/>
 <result pre="carcinoma: opposing roles of CD151 in invasive lobular and ductal" exact="breast" post="cancers.Br. J. Cancer1131350â€&quot;1357. 10.1038/bjc.2015.34426418423 RosenblumD.JoshiN.TaoW.KarpJ. M.PeerD. (2018). Progress and"/>
 <result pre="RosenblumD.JoshiN.TaoW.KarpJ. M.PeerD. (2018). Progress and challenges towards targeted delivery of" exact="cancer" post="therapeutics.Nat. Commun.9:1410. 10.1038/s41467-018-03705-y29650952 SachsN.KreftM.Van Den Bergh WeermanM. A.BeynonA. J.PetersT."/>
 <result pre="SachsN.KreftM.Van Den Bergh WeermanM. A.BeynonA. J.PetersT. A.WeeningJ. J.et al. (2006)." exact="Kidney" post="failure in mice lacking the tetraspanin CD151.J. Cell Biol.17533â€&quot;39."/>
 <result pre="Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in" exact="tumor" post="metastasis.Cancer Res.706059â€&quot;6070. 10.1158/0008-5472.CAN-09-349720570898 Sandfeld-PaulsenB.JakobsenK. R.BaekR.FolkersenB. H.RasmussenT. R.MeldgaardP.et al. (2016)."/>
 <result pre="tetraspanin CD151 in papillomavirus infection.Viruses6893â€&quot;908. 10.3390/v602089324553111 ShigetaM.SanzenN.OzawaM.GuJ.HasegawaH.SekiguchiK. (2003). CD151 regulates" exact="epithelial" post="cell-cell adhesion through PKC- and Cdc42-dependent actin cytoskeletal reorganization.J."/>
 <result pre="reorganization.J. Cell Biol.163165â€&quot;176. 10.1083/jcb.20030107514557253 ShimJ. M.KimJ.TensonT.MinJ. Y.KainovD. E. (2017). Influenza" exact="virus infection," post="interferon response, viral counter-response, and apoptosis.Viruses9:E223. 10.3390/v908022328805681 ShiomiT.InokiI.KataokaF.OhtsukaT.HashimotoG.NemoriR.et al."/>
 <result pre="ShimJ. M.KimJ.TensonT.MinJ. Y.KainovD. E. (2017). Influenza virus infection, interferon response," exact="viral" post="counter-response, and apoptosis.Viruses9:E223. 10.3390/v908022328805681 ShiomiT.InokiI.KataokaF.OhtsukaT.HashimotoG.NemoriR.et al. (2005). Pericellular activation"/>
 <result pre="SuzukiS.MiyazakiT.TanakaN.SakaiM.SanoA.InoseT.et al. (2011). Prognostic significance of CD151 expression in esophageal" exact="squamous cell carcinoma" post="with aggressive cell proliferation and invasiveness.Ann. Surg. Oncol.18888â€&quot;893. 10.1245/s10434-010-1387-320978946"/>
 <result pre="(2011). Prognostic significance of CD151 expression in esophageal squamous cell" exact="carcinoma" post="with aggressive cell proliferation and invasiveness.Ann. Surg. Oncol.18888â€&quot;893. 10.1245/s10434-010-1387-320978946"/>
 <result pre="and in vitro.Blood109:1524. 10.1182/blood-2006-08-04197017023588 TakedaY.LiQ.KazarovA. R.EpardaudM.ElpekK.TurleyS. J.et al. (2011). Diminished" exact="metastasis" post="in tetraspanin CD151â€&quot;knockout mice.Blood118:464. 10.1182/blood-2010-08-30224021536858 TestaJ. E.BrooksP. C.LinJ. M.QuigleyJ."/>
 <result pre="antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human" exact="tumor" post="cell migration and metastasis.Cancer Res.593812â€&quot;3820. 10447000 ThaliM. (2011). Tetraspanin"/>
 <result pre="significance of CD151 gene expression in non-small cell lung cancer.Clin." exact="Cancer" post="Res.74109â€&quot;4114. 11751509 TsujinoK.TakedaY.AraiT.ShintaniY.InagakiR.SaigaH.et al. (2012). Tetraspanin CD151 protects against"/>
 <result pre="Cancer Res.74109â€&quot;4114. 11751509 TsujinoK.TakedaY.AraiT.ShintaniY.InagakiR.SaigaH.et al. (2012). Tetraspanin CD151 protects against" exact="pulmonary" post="fibrosis by maintaining epithelial integrity.Am. J. Respir. Crit. Care"/>
 <result pre="al. (2012). Tetraspanin CD151 protects against pulmonary fibrosis by maintaining" exact="epithelial" post="integrity.Am. J. Respir. Crit. Care Med.186170â€&quot;180. 10.1164/rccm.201201-0117OC22592804 VahidnezhadH.YoussefianL.SaeidianA. H.MahmoudiH.TouatiA.AbiriM.et"/>
 <result pre="J. Respir. Crit. Care Med.186170â€&quot;180. 10.1164/rccm.201201-0117OC22592804 VahidnezhadH.YoussefianL.SaeidianA. H.MahmoudiH.TouatiA.AbiriM.et al. (2018)." exact="Recessive" post="mutation in tetraspanin CD151 causes Kindler syndrome-like epidermolysis bullosa"/>
 <result pre="al. (2018). Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like" exact="epidermolysis bullosa" post="with multi-systemic manifestations including nephropathy.Matrix Biol.6622â€&quot;33. 10.1016/j.matbio.2017.11.00329138120 van SprielA."/>
 <result pre="G. (2010). The role of tetraspanins in the pathogenesis of" exact="infectious" post="diseases.Microbes Infect.12106â€&quot;112. 10.1016/j.micinf.2009.11.00119896556 WrightM. D.GearyS. M.FitterS.MoseleyG. W.LauL. M.ShengK. C.et"/>
 <result pre="Biol.245978â€&quot;5988. 10.1128/mcb.24.13.5978-5988.200415199151 YamadaM.SumidaY.FujibayashiA.FukaguchiK.SanzenN.NishiuchiR.et al. (2008). The tetraspanin CD151 regulates cell" exact="morphology" post="and intracellular signaling on laminin-511.FEBS J.2753335â€&quot;3351. 10.1111/j.1742-4658.2008.06481.x18492066 YanY.LiuL.XiongH.MillerJ. B.ZhouK.KosP.et"/>
 <result pre="B.ZhouK.KosP.et al. (2016). Functional polyesters enable selective siRNA delivery to" exact="lung cancer" post="over matched normal cells.Proc. Natl. Acad. Sci. U.S.A.113E5702â€&quot;E5710. 10.1073/pnas.160688611327621434"/>
 <result pre="al. (2016). Functional polyesters enable selective siRNA delivery to lung" exact="cancer" post="over matched normal cells.Proc. Natl. Acad. Sci. U.S.A.113E5702â€&quot;E5710. 10.1073/pnas.160688611327621434"/>
 <result pre="E.et al. (2010). Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes" exact="breast cancer" post="cells to ErbB2 antagonists.Cancer Res.702256â€&quot;2263. 10.1158/0008-5472.CAN-09-403220197472 YangX. H.RichardsonA. L.Torres-ArzayusM."/>
 <result pre="al. (2010). Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast" exact="cancer" post="cells to ErbB2 antagonists.Cancer Res.702256â€&quot;2263. 10.1158/0008-5472.CAN-09-403220197472 YangX. H.RichardsonA. L.Torres-ArzayusM."/>
 <result pre="10.1158/0008-5472.CAN-09-403220197472 YangX. H.RichardsonA. L.Torres-ArzayusM. I.ZhouP.SharmaC.KazarovA. R.et al. (2008). CD151 accelerates" exact="breast cancer" post="by regulating Î±(6) integrin function, signaling, and molecular organization.Cancer"/>
 <result pre="YangX. H.RichardsonA. L.Torres-ArzayusM. I.ZhouP.SharmaC.KazarovA. R.et al. (2008). CD151 accelerates breast" exact="cancer" post="by regulating Î±(6) integrin function, signaling, and molecular organization.Cancer"/>
 <result pre="and Tspan8 are essential exosome components for the crosstalk between" exact="cancer" post="initiating cells and their surrounding.Oncotarget62366â€&quot;2384. 25544774 ZevianS.WinterwoodN. E.StippC. S."/>
 <result pre="(2011). Structure-function analysis of tetraspanin CD151 reveals distinct requirements for" exact="tumor" post="cell behaviors mediated by alpha3beta1 versus alpha6beta4 integrin.J. Biol."/>
 <result pre="integrin.J. Biol. Chem.2867496â€&quot;7506. 10.1074/jbc.M110.17358321193415 ZijlstraA.LewisJ.DegryseB.StuhlmannH.QuigleyJ. P. (2008). The inhibition of" exact="tumor" post="cell intravasation and subsequent metastasis via regulation of in"/>
 <result pre="P. (2008). The inhibition of tumor cell intravasation and subsequent" exact="metastasis" post="via regulation of in vivo tumor cell motility by"/>
 <result pre="cell intravasation and subsequent metastasis via regulation of in vivo" exact="tumor" post="cell motility by the tetraspanin CD151.Cancer Cell13221â€&quot;234. 10.1016/j.ccr.2008.01.03118328426"/>
</results>
